Elias Alharari
Psychiatric/Mental Health · Frisco, TXNPI 1588104541
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 76.6% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $19,778, more than ten times the $47 reported in 2021. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 740 payments — averaging $55.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$32K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Corium, LLC$731
- Teva Pharmaceuticals USA, Inc.$699
- Otsuka America Pharmaceutical, Inc.$682
- plus $5K from 26 others
What the payments were for
- Consulting fees$1,4504%
- Speaking & faculty fees$24,43059%
- Travel & lodging$2,4786%
- Food & beverage$12,94231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 207 | $31,650 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 69 | $1,482 |
| AbbVie | 77 | $1,100 |
| Corium, LLC | 35 | $731 |
| Teva Pharmaceuticals USA, Inc. | 35 | $699 |
| Otsuka America Pharmaceutical, Inc. | 47 | $682 |
| Lundbeck LLC | 40 | $625 |
| Alkermes, Inc. | 28 | $613 |
| Neurocrine Biosciences, Inc. | 28 | $530 |
| E.r. Squibb & Sons, L.L.C. | 25 | $464 |
| Ironshore Pharmaceuticals Inc. | 27 | $382 |
| Tris Pharma Inc | 13 | $241 |
| Indivior Inc. | 10 | $238 |
| Supernus Pharmaceuticals, Inc. | 12 | $222 |
| Vanda Pharmaceuticals Inc. | 9 | $219 |
| Axsome Therapeutics, Inc. | 12 | $195 |
| Sunovion Pharmaceuticals Inc. | 14 | $165 |
| Janssen Scientific Affairs, LLC | 3 | $163 |
| Neos Therapeutics, LP | 7 | $133 |
| Braeburn Inc. | 5 | $128 |
| Merck | 7 | $108 |
| Almatica Pharma LLC | 6 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $100 |
| Idorsia Pharmaceuticals US Inc | 4 | $76 |
| Noven Therapeutics, LLC | 4 | $71 |
| Sage Therapeutics, LLC | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Orexo US, Inc. | 2 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Avion Pharmaceuticals | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$28,930
How this compares
$41,299 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 27 | $67,990 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $5,522 |
| Loreev XrLorazepam | 12 | $5,196 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $479 |
| Trazodone Hcl | 29 | $344 |
| Doxepin Hcl | 12 | $273 |
| Buspirone Hcl | 27 | $220 |
| Gabapentin | 13 | $193 |
| Bupropion XlBupropion Hcl | 22 | $176 |
| Prazosin Hcl | 13 | $134 |
| Mirtazapine | 18 | $102 |
| Escitalopram Oxalate | 14 | $85 |
| Lorazepam | 19 | $54 |
| Clonazepam | 18 | $46 |
| Sertraline Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $31,650 | $67,99027 claims |
| Almatica Pharma LLCLoreev Xr, Sertraline Hcl | $105 | $5,21824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Frisco
- Karen HensonFrisco$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.